Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Sumitomo Pharma Co Ltd banner

Sumitomo Pharma Co Ltd
OTC:SMDPY

Watchlist Manager
Sumitomo Pharma Co Ltd Logo
Sumitomo Pharma Co Ltd
OTC:SMDPY
Watchlist
Price: 10.45 USD
Market Cap: $4.2B
Write Note Create Alert Ask AI

Wall St Price Targets

SMDPY Price Targets Summary
Sumitomo Pharma Co Ltd

Wall Street analysts forecast SMDPY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SMDPY is 12.99 USD with a low forecast of 10.43 USD and a high forecast of 19.52 USD.

SMDPY Lowest Forecast
Wall Street Target
$10.43
0% Downside
SMDPY Average Forecast
Wall Street Target
$12.99
24% Upside
SMDPY Highest Forecast
Wall Street Target
$19.52
87% Upside
Lowest Forecast
Price Target
10.43 USD
0% Downside
Average Forecast
Price Target
12.99 USD
24% Upside
Highest Forecast
Price Target
19.52 USD
87% Upside
Sumitomo Pharma Co Ltd Competitors:
Price Targets

Revenue
Forecast

2% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
2% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 3 years is 11%.

What are analyst estimates?

Gross Profit
Forecast

0% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
0% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 3 years is 9%.

What are analyst estimates?

Operating Income
Forecast

7% / Year
Past Growth
-83% / Year
Estimated Growth
Estimates Accuracy
20%
Average Beat
7% / Year
Past Growth
-83% / Year
Estimated Growth
Estimates Accuracy
20%
Average Beat

Over the last 13 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 1 year is -83%.

What are analyst estimates?

Pre-Tax Income
Forecast

14% / Year
Past Growth
-4% / Year
Estimated Growth
Estimates Accuracy
9%
Average Beat
14% / Year
Past Growth
-4% / Year
Estimated Growth
Estimates Accuracy
9%
Average Beat

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 14%. The projected CAGR for the next 3 years is -4%.

What are analyst estimates?

Net Income
Forecast

20% / Year
Past Growth
-14% / Year
Estimated Growth
Estimates Accuracy
14%
Average Beat
20% / Year
Past Growth
-14% / Year
Estimated Growth
Estimates Accuracy
14%
Average Beat

Over the last 13 years, the compound annual growth rate for Net Income has been 20%. The projected CAGR for the next 3 years is -14%.

What are analyst estimates?

Continue SMDPY Research

Summary
SMDPY intrinsic value, competitors valuation, and company profile.
DCF Valuation
SMDPY stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SMDPY stock valuation using valuation multiples.
Wall St Estimates
SMDPY price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SMDPY stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Sumitomo Pharma Co Ltd listings:
OTC • USD
DNPUF
 F • EUR
DPM
 TSE • JPY
4506
 XMUN • EUR
DPM
 SWB • EUR
DPM
 DUS • EUR
DPM
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is SMDPY's stock price target?
Price Target
12.99 USD

According to Wall Street analysts, the average 1-year price target for SMDPY is 12.99 USD with a low forecast of 10.43 USD and a high forecast of 19.52 USD.

What is the Revenue forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
11%

Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 3 years is 11%.

What is the Gross Profit forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
9%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 3 years is 9%.

What is the Operating Income forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
-83%

Over the last 13 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 1 year is -83%.

What is the Pre-Tax Income forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
-4%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 14%. The projected CAGR for the next 3 years is -4%.

What is the Net Income forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
-14%

Over the last 13 years, the compound annual growth rate for Net Income has been 20%. The projected CAGR for the next 3 years is -14%.

Back to Top
ALPHA SPREAD
Follow us
Join 357,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.